Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (91-100 of 328) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndromeHiroki Yano, Takashi Ishida, Atsushi Inagaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 12, 2018
[Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma]Shinsuke Iida, Tohru Izumi, Nobuyuki Aotsuka, et al.
Pathology International|September 29, 2016
Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sectionsJunki Kato, Ayako Masaki, Keiichiro Fujii, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myelomaTomoko Kodama, Masahiro Abe, Shinsuke Iida, et al.
International Journal of Hematology|September 23, 2022
Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutationShiori Kinoshita, Hirokazu Komatsu, Haruna Fujinami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2015
Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumabHideki Ifuku, Shigeru Kusumoto, Yasuhito Tanaka, et al.
Pathology International|September 5, 2017
Improved clonality detection in B-cell lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH rearrangement: A paraffin-embedded tissue studyYuma Sakamoto, Ayako Masaki, Satsuki Aoyama, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|July 15, 2016
Does cognitive decline decrease health utility value in older adult patients with cancer?Tatsuo Akechi, Sayo Aiki, Koji Sugano, et al.
Japanese Journal of Clinical Oncology|May 25, 2024
Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3Shinsuke Iida, Satoshi Ito, Hisayuki Yokoyama, et al.
International Journal of Clinical Oncology|October 2, 2021
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myelomaShinsuke Iida, Tohru Izumi, Takuya Komeno, et al.
Pageof 33

Showing results (91-100 of 328) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndromeHiroki Yano, Takashi Ishida, Atsushi Inagaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 12, 2018
[Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma]Shinsuke Iida, Tohru Izumi, Nobuyuki Aotsuka, et al.
Pathology International|September 29, 2016
Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sectionsJunki Kato, Ayako Masaki, Keiichiro Fujii, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myelomaTomoko Kodama, Masahiro Abe, Shinsuke Iida, et al.
International Journal of Hematology|September 23, 2022
Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutationShiori Kinoshita, Hirokazu Komatsu, Haruna Fujinami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2015
Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumabHideki Ifuku, Shigeru Kusumoto, Yasuhito Tanaka, et al.
Pathology International|September 5, 2017
Improved clonality detection in B-cell lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH rearrangement: A paraffin-embedded tissue studyYuma Sakamoto, Ayako Masaki, Satsuki Aoyama, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|July 15, 2016
Does cognitive decline decrease health utility value in older adult patients with cancer?Tatsuo Akechi, Sayo Aiki, Koji Sugano, et al.
Japanese Journal of Clinical Oncology|May 25, 2024
Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3Shinsuke Iida, Satoshi Ito, Hisayuki Yokoyama, et al.
International Journal of Clinical Oncology|October 2, 2021
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myelomaShinsuke Iida, Tohru Izumi, Takuya Komeno, et al.
Pageof 33